magazinelogo

International Journal of Clinical and Experimental Medicine Research

ISSN Online: 2575-7970 Downloads: 324386 Total View: 3033466
Frequency: bimonthly ISSN Print: 2575-7989 CODEN: IJCEMH
Email: ijcemr@hillpublisher.com
Article Open Access http://dx.doi.org/10.26855/ijcemr.2021.07.019

A Case of Familial Mediterranean Fever Presenting with Pseudo-Bartter Syndrome

Can Hüzmeli1,*, Emine Uslu Yurteri2, Mustafa Bardakçı3

1Department of Nephrology, Hatay Education and Research Hospital, Hatay, Turkey.

2Department of Rheumatology, Hatay Education and Research Hospital, Hatay, Turkey.

3Department of Radiology, Hatay Education and Research Hospital, Hatay, Turkey.

*Corresponding author: Can Hüzmeli

Published: July 1,2021

Abstract

Bartter Syndrome is a disease (sporadic or familial) characterized by hypochloremia, hypokalemia, hyponatremia, metabolic alkalosis, hyperaldosteronism, hyperreninemia and normal blood pressure. Pseudo-Bartter syndrome is characterized by hypochloremia associated with metabolic alkalosis and hypokalemia without any pathology in the tubular transport mechanism. Bartter syndrome and pseudo bartter syndrome have similar biochemical profile. Pseudo-Bartter syndrome is different from Bartter syndrome as extrarenal electrolyte loss occurs. Pseudo-Bartter syndrome may develop as a result of cystic fibrosis, inappropriate diuretic use, chlorine-poor diet, bulimia, cyclic vomit-ing, and laxative abuse. In the treatment of pseudo-bartter syndrome, the treatment of the underlying disease and the provision of fluid and electrolyte balance. Familial Mediterranean fever is characterized by non-infectious recurrent episodes of fever and serositis and is an autosomal recessive genetic disease that can develop amyloidosis over time. In this paper, we made the diagnosis of Familial Mediterranean fever in an 18-year-old male patient who presented with pseudo-Bartter syndrome. The association of pseudo-Bartter syndrome and Familial Mediterranean fever has not been previously described in the literature.

References

[1] Heilberg, I. P., Tótoli, C., Calado, J. T. (2015). Adult presentation of Bartter syndrome type IV with erythrocytosis. Einstein (Sao Paulo), 2015, 13(4): 604-606. https://doi.org/10.1590/S1679-45082015RC3013.

[2] Gürsu, M., Öztürk, S., Aydin, Z., Uzun, S., Kazancioğlu, R. (2009). Ağır Metabolik Alkalozla Seyreden Bir Pseudo-Bartter Olgusu (A Case of Pseudo-Bartter Syndrome with Severe Metabolic Alkalosis). Turkish Nephrology, Dialysis and Transplantation Journal, 2009, 18: 136-139.

[3] da Silva Cunha, T., Heilberg, I. P. “Bartter syndrome: causes, diagnosis, and treatment.” International Journal of Nephrology and Renovascular Disease, 2018, 11: 291. 10.2147/IJNRD.S155397.

[4] Migita, K., Asano, T., Sato, S., Koga, T., Fujita, Y., Kawakami, A. (2018). “Familial Mediterranean fever: overview of pathogenesis, clinical features and management.” Immunological Medicine, 41.2(2018): 55-61.3. https://doi.org/10.1080/13497413. 2018.1481579.

[5] Kumar, J. S. (2020). “Bartter Syndrome.” Asian Journal of Nursing Education and Research, 2020, 10(4): 509-511.

[6] Mantoo, M. R., Kabra, M., Kabra, S. K. (2020). “Cystic Fibrosis Presenting as Pseudo-Bartter Syndrome: An Important Diagnosis that is Missed!” Indian J Pediatr., 2020. https://doi.org/10.1007/s12098-020-03342-8.

How to cite this paper

A Case of Familial Mediterranean Fever Presenting with Pseudo-Bartter Syndrome

How to cite this paper: Can Hüzmeli, Emine Uslu Yurteri, Mustafa Bardakçı. (2021) A Case of Familial Mediterranean Fever Presenting with Pseudo-Bartter Syndrome. International Journal of Clinical and Experimental Medicine Research5(3), 353-355.

DOI: http://dx.doi.org/10.26855/ijcemr.2021.07.019